share_log

Comera Life Sciences(CMRA.US)首席科学官增持2万股普通股股份,价值约为1.25万美元

The Chief Scientific Officer of Comera Life Sciences (CMRA.US) increased his holdings of common stock by 20,000 shares, worth approximately US$12,500

Futu News ·  Aug 16, 2023 04:53

It was reported on August 16 that according to documents disclosed by the US Securities and Exchange Commission (SEC) on August 15,$Comera Life Sciences (CMRA.US)$Chief Science Officer Mahoney Robert Patrick increased his holdings of common shares by 20,000 shares at an average price of $0.6252 per share on August 14, worth about US$12,500.

1692130803793287217.png

What is a statement of change in shareholding?

The SEC requires insiders of listed companies to publicly disclose their securities transactions and shareholding. When an insider's shareholding changes, depending on different circumstances, it is necessary to submit a statement of change in shareholding to the SEC within a certain period of time after the transaction is completed.

Insiders include the company's directors and executives, as well as any shareholder who owns 10% or more of the company's tradable shares.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment